Dr Nicholas Vincent Varrati Iii, MD | |
306 W High Ave, New Philadelphia, OH 44663-2134 | |
(330) 339-9211 | |
(330) 339-8858 |
Full Name | Dr Nicholas Vincent Varrati Iii |
---|---|
Gender | Male |
Speciality | |
Experience | Years |
Location | 306 W High Ave, New Philadelphia, Ohio |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1932165230 | NPI | - | NPPES |
0581400 | Medicaid | OH |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208VP0000X | Pain Medicine - Pain Medicine | 35050153 (Ohio) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Nicholas Vincent Varrati Iii, MD 306 W High Ave, New Philadelphia, OH 44663-2134 Ph: (330) 339-9211 | Dr Nicholas Vincent Varrati Iii, MD 306 W High Ave, New Philadelphia, OH 44663-2134 Ph: (330) 339-9211 |
News Archive
In its effort to improve and expedite the disability determination process, the Social Security Administration has announced that it will add early-onset Alzheimer's disease to its Compassionate Allowances Initiative. The initiative identifies debilitating diseases and medical conditions that meet the SSA's disability standards for Social Security Disability Income (SSDI) or Supplemental Security Income (SSI).
All the tired ideas from 2011 and 2012 are back: eliminating Medicare's guarantee to retirees by turning it into a voucher plan; dispensing with Medicaid and food stamps by turning them into block grants for states to cut freely; repealing most of the reforms to health care and Wall Street; shrinking beyond recognition the federal role in education, job training, transportation and scientific and medical research.
Cost and quality issues in the news include research about the costliest U.S. patients, the potential that delaying aging instead of treating disease could have on extending life, and examining how the U.S. compares to other countries on approving new medical treatments.
In the framework of the European project FLEXPOL, members of the UA NANOBIOPOL group are designing formulations with antimicrobial properties from essential oils.
› Verified 5 days ago